Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

High rate of disease-related copy number variations in childhood onset schizophrenia

Abstract

Copy number variants (CNVs) are risk factors in neurodevelopmental disorders, including autism, epilepsy, intellectual disability (ID) and schizophrenia. Childhood onset schizophrenia (COS), defined as onset before the age of 13 years, is a rare and severe form of the disorder, with more striking array of prepsychotic developmental disorders and abnormalities in brain development. Because of the well-known phenotypic variability associated with pathogenic CNVs, we conducted whole genome genotyping to detect CNVs and then focused on a group of 46 rare CNVs that had well-documented risk for adult onset schizophrenia (AOS), autism, epilepsy and/or ID. We evaluated 126 COS probands, 69 of which also had a healthy full sibling. When COS probands were compared with their matched related controls, significantly more affected individuals carried disease-related CNVs (P=0.017). Moreover, COS probands showed a higher rate than that found in AOS probands (P<0.0001). A total of 15 (11.9%) subjects exhibited at least one such CNV and four of these subjects (26.7%) had two. Five of 15 (4.0% of the sample) had a 2.5–3 Mb deletion mapping to 22q11.2, a rate higher than that reported for adult onset (0.3–1%) (P<0.001) or autism spectrum disorder and, indeed, the highest rate reported for any clinical population to date. For one COS subject, a duplication found at 22q13.3 had previously only been associated with autism, and for four patients CNVs at 8q11.2, 10q22.3, 16p11.2 and 17q21.3 had only previously been associated with ID. Taken together, these findings support the well-known pleiotropic effects of these CNVs suggesting shared abnormalities early in brain development. Clinically, broad CNV-based population screening is needed to assess their overall clinical burden.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 4th edn. American Psychiatric Association: Washington, DC, USA, 1994 p 866.

  2. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–1689.

    Article  CAS  PubMed  Google Scholar 

  3. Murrell J, Farlow M, Ghetti B, Benson MD . A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 1991; 254: 97–99.

    Article  CAS  PubMed  Google Scholar 

  4. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539–543.

    Article  CAS  PubMed  Google Scholar 

  5. Ingason A, Rujescu D, Cichon S, Sigurdsson E, Sigmundsson T, Pietilainen OP et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry 2011; 16: 17–25.

    Article  CAS  PubMed  Google Scholar 

  6. ISC. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237–241.

    Article  Google Scholar 

  7. Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet 2009; 18: 1497–1503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009; 41: 1223–1227.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rujescu D, Ingason A, Cichon S, Pietilainen OP, Barnes MR, Toulopoulou T et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 2009; 18: 988–996.

    Article  CAS  PubMed  Google Scholar 

  10. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008; 455: 232–236.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744–747.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Consortium IS. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237–241.

    Article  Google Scholar 

  13. Ingason A, Rujescu D, Cichon S, Sigurdsson E, Sigmundsson T, Pietilainen OP et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry 2009; 16: 17–25.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mefford HC, Eichler EE . Duplication hotspots, rare genomic disorders, and common disease. Curr Opin Genet Dev 2009; 19: 196–204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Shinawi M, Liu P, Kang SH, Shen J, Belmont JW, Scott DA et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010; 47: 332–341.

    Article  CAS  PubMed  Google Scholar 

  16. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358: 667–675.

    Article  CAS  PubMed  Google Scholar 

  17. O'Donovan MC, Kirov G, Owen MJ . Phenotypic variations on the theme of CNVs. Nat Genet 2008; 40: 1392–1393.

    Article  CAS  PubMed  Google Scholar 

  18. van Bon BW, Mefford HC, Menten B, Koolen DA, Sharp AJ, Nillesen WM et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009; 46: 511–523.

    Article  CAS  PubMed  Google Scholar 

  19. Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, Franke A et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009; 41: 160–162.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, Leu C et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010; 133 (Part 1): 23–32.

    Article  PubMed  Google Scholar 

  21. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 2011; 168: 302–316.

    PubMed  PubMed Central  Google Scholar 

  22. Miller DT, Shen Y, Weiss LA, Korn J, Anselm I, Bridgemohan C et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 2009; 46: 242–248.

    Article  CAS  PubMed  Google Scholar 

  23. Sharp AJ, Mefford HC, Li K, Baker C, Skinner C, Stevenson RE et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008; 40: 322–328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011; 70: 863–885.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Girirajan S, Brkanac Z, Coe BP, Baker C, Vives L, Vu TH et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011; 7: e1002334.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kumra S, Frazier JA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC et al. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 1996; 53: 1090–1097.

    Article  CAS  PubMed  Google Scholar 

  27. Shaw P, Sporn A, Gogtay N, Overman GP, Greenstein D, Gochman P et al. Childhood-onset schizophrenia: a double-blind, randomized clozapine–olanzapine comparison. Arch Gen Psychiatry 2006; 63: 721–730.

    Article  CAS  PubMed  Google Scholar 

  28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007; 17: 1665–1674.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P et al. QuantiSNP: an objective Bayes hidden-Markov model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res 2007; 35: 2013–2025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, Hou C et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci USA 2010; 107: 10584–10589.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Guha S, Rees E, Darvasi A, Ivanov D, Ikeda M, Bergen SE et al. Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA Psychiatry 2013; 70: 253–260.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Bassett AS, Chow EW . Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep 2008; 10: 148–157.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C . Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil 2009; 30: 763–773.

    Article  PubMed  Google Scholar 

  35. Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Heineman-de Boer JA, Beemer FA et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 2006; 45: 1104–1113.

    Article  PubMed  Google Scholar 

  36. Goodship J, Cross I, LiLing J, Wren C . A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 1998; 79: 348–351.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 2009; 5: e1000373.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Grozeva D, Conrad DF, Barnes CP, Hurles M, Owen MJ, O’Donovan MC et al. Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr Res 2012; 135: 1–7.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hoogendoorn ML, Vorstman JA, Jalali GR, Selten JP, Sinke RJ, Emanuel BS et al. Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr Res 2008; 98: 84–88.

    Article  PubMed  Google Scholar 

  40. Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N . Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry 2009; 48: 10–18.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Vorstman JA, Breetvelt EJ, Thode KI, Chow EW, Bassett AS . Expression of autism spectrum and schizophrenia in patients with a 22q11.2 deletion. Schizophr Res 2012; 143: 55–59.

    Article  PubMed  Google Scholar 

  42. Lee Y, Mattai A, Long R, Rapoport JL, Gogtay N, Addington AM . Microduplications disrupting the MYT1L gene (2p25.3) are associated with schizophrenia. Psychiatr Genet 2012; 22: 206–209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I, Strengman E, Sabatti C, Geurts van Kessel A et al. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 2008; 83: 504–510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Balciuniene J, Feng N, Iyadurai K, Hirsch B, Charnas L, Bill BR et al. Recurrent 10q22–q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities. Am J Hum Genet 2007; 80: 938–947.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. van Bon BW, Balciuniene J, Fruhman G, Nagamani SC, Broome DL, Cameron E et al. The phenotype of recurrent 10q22q23 deletions and duplications. Eur J Hum Genet 2011; 19: 400–408.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Bachmann-Gagescu R, Mefford HC, Cowan C, Glew GM, Hing AV, Wallace S et al. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet Med 2010; 12: 641–647.

    Article  PubMed  Google Scholar 

  47. Grisart B, Willatt L, Destree A, Fryns JP, Rack K, de Ravel T et al. 17q21.31 microduplication patients are characterised by behavioural problems and poor social interaction. J Med Genet 2009; 46: 524–530.

    Article  CAS  PubMed  Google Scholar 

  48. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007; 39: 25–27.

    Article  CAS  PubMed  Google Scholar 

  49. Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N . Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry 2009; 48: 10–18.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012; 367: 1321–1331.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011; 43: 838–846.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J L Rapoport.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahn, K., Gotay, N., Andersen, T. et al. High rate of disease-related copy number variations in childhood onset schizophrenia. Mol Psychiatry 19, 568–572 (2014). https://doi.org/10.1038/mp.2013.59

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2013.59

Keywords

This article is cited by

Search

Quick links